Hester Biosciences Makes Q3 FY26 Earnings Call Recording Available Online

1 min read     Updated on 30 Jan 2026, 04:11 PM
scanx
Reviewed by
Naman SScanX News Team
Overview

Hester Biosciences Limited has made its Q3 FY26 earnings conference call audio recording available on the company website following the teleconference held on 30 January 2026. The call discussed financial results for the quarter and nine months period ended 31 December 2025, with the recording now accessible to all shareholders and investors in compliance with SEBI disclosure regulations.

31315289

*this image is generated using AI for illustrative purposes only.

Hester biosciences Limited has announced that the audio recording of its earnings conference call for Q3 FY26 results is now available on the company's official website. The teleconference was conducted on 30 January 2026 to discuss the financial performance for the quarter and nine months period ended 31 December 2025.

Regulatory Compliance and Disclosure

The company has made this announcement in compliance with Regulations 30 and 46(2)(oa) of the SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015. This regulatory framework mandates listed companies to ensure transparency and timely disclosure of material information to stakeholders.

Access Details

The earnings call recording has been made accessible to all shareholders and investors through the company's dedicated investor relations section. The audio recording can be accessed through the company's website at the earnings call section.

Parameter: Details
Conference Date: 30 January 2026
Results Period: Quarter and nine months ended 31 December 2025
Access Method: Company website
Target Audience: All shareholders and investors

Corporate Communication

The formal communication was signed by Vinod Mali, Company Secretary & Compliance Officer, and submitted to both major stock exchanges where Hester Biosciences shares are listed. The notification was sent to BSE Limited and National Stock Exchange of India Limited on 30 January 2026.

Stakeholder Engagement

By making the earnings call recording available online, Hester Biosciences ensures that stakeholders who could not participate in the live teleconference can access the management's commentary on quarterly performance. This approach enhances transparency and provides equal access to material information for all investors and shareholders.

Historical Stock Returns for Hester Biosciences

1 Day5 Days1 Month6 Months1 Year5 Years
+3.05%+3.41%-6.31%-19.50%-29.18%-11.90%

Hester Biosciences Schedules Q3FY26 Results Conference Call for January 30, 2026

1 min read     Updated on 23 Jan 2026, 02:32 PM
scanx
Reviewed by
Radhika SScanX News Team
Overview

Hester Biosciences Limited has scheduled an earnings conference call for January 30, 2026, at 2:00 PM IST to discuss Q3FY26 and nine-month financial results ended December 31, 2025. The call will be represented by CEO Rajiv Gandhi, Executive Director Priya Gandhi, and CFO Ashish Desai, with ICICI Securities coordinating the investor interaction in compliance with SEBI regulations.

30704574

*this image is generated using AI for illustrative purposes only.

Hester biosciences Limited has announced an earnings conference call to discuss its financial performance for the third quarter and nine months of fiscal year 2026. The company filed an official intimation with stock exchanges on January 23, 2026, informing investors about the scheduled teleconference.

Conference Call Details

The earnings discussion is scheduled for January 30, 2026, at 2:00 PM Indian Standard Time. This investor interaction will take place following the announcement of financial results for the quarter and nine months period ended December 31, 2025.

Parameter: Details
Date: Friday, January 30, 2026
Time: 2:00 PM IST
Format: Teleconference Call
Period Covered: Q3FY26 and 9M FY26
Results Period: Quarter and nine months ended December 31, 2025

Management Representation

The conference call will feature senior management personnel who will present the company's financial performance and address investor queries. The management team participating in the call includes key executives from various operational areas.

Role: Representative
CEO & Managing Director: Mr. Rajiv Gandhi
Executive Director: Ms. Priya Gandhi
Chief Financial Officer: Mr. Ashish Desai

Regulatory Compliance

The earnings conference call announcement was made in compliance with Regulation 30 of the SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015. The company submitted the intimation to both BSE Limited and National Stock Exchange of India Limited on January 23, 2026.

ICICI Securities is coordinating the investor interaction session and has provided registration details for participants. The brokerage firm has designated multiple contact persons to assist investors with call-related queries and clarifications.

Coordination and Contact Information

ICICI Securities has appointed Mr. Jaideep Goswami, Head of Equities, as the primary call coordinator. Additional support staff including Mr. Abdulkader Puranwala, Mr. Rushad Kapadia, Ms. Seema Sehgal, and Ms. Minali Ginwala have been designated to handle investor queries and provide technical assistance for the conference call participation.

Historical Stock Returns for Hester Biosciences

1 Day5 Days1 Month6 Months1 Year5 Years
+3.05%+3.41%-6.31%-19.50%-29.18%-11.90%

More News on Hester Biosciences

1 Year Returns:-29.18%